Overview

Use of Low-dose Zolpidem in Parkinson's Disease

Status:
Completed
Trial end date:
2020-01-24
Target enrollment:
Participant gender:
Summary
This study will evaluate the motor and cognitive benefits of low-dose zolpidem in Parkinson's.
Phase:
Phase 2
Details
Lead Sponsor:
Aston University
Collaborator:
University Hospital Birmingham NHS Foundation Trust
Treatments:
Zolpidem